Ascendis Pharma A (ASND) Return on Equity (2021 - 2022)

Ascendis Pharma A's (ASND) quarterly Return on Equity came in at 0.02% in Q4 2022, down 75.79% quarter-over-quarter from 0.01% in Q3 2022.

Ascendis Pharma A (ASND) Return on Equity (2021 - 2022) Analysis & Trends

Ascendis Pharma A has disclosed Return on Equity across 2 years of filings, most recently posting 0.02% for Q4 2022.

Return on Equity for Q4 2022 came in at 0.02%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was 0.02% (changed N/A YoY), and the FY2025 annual result was 0.01%, down 2.0% from the prior year.
Return on Equity came in at 0.02% for Q4 2022 at Ascendis Pharma A, down from 0.01% in the prior quarter.
In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2021 to a low of 0.02% in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROE (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-0.81%
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-0.04%
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	0.00%
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-0.01%
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	0.00%
9	Abivax	91.96 Bn	91.96 Bn	-	-0.01%
10	Ascendis Pharma A	2.75 Bn	2.08 Bn	268.20 Mn	-

Download Data